On August 1, 2019 Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, reported that company management will participate in three upcoming conferences (Press release, Xencor, AUG 1, 2019, View Source [SID1234538043]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Canaccord Genuity 39th Annual Growth Conference
Date: Thursday, August 8, 2019
Location: Boston, MA
BTIG Biotechnology Conference 2019
Date: Monday, August 12, 2019
Location: New York, NY
2019 Wedbush PacGrow Healthcare Conference
Date: Tuesday, August 13, 2019
Location: New York, NY
Presentation Time: 10:20 a.m. ET
A live webcast of 2019 Wedbush PacGrow Healthcare Conference will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. A replay of the event will be posted on the Xencor website approximately one hour after the live event and will be available for 30 days following the presentation.